Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2023

Dec 4, 2023

29745_dirs_2023-12-04_d6d99514-1440-4b60-89c4-28f645584c7a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-12-01

Reporting Person: Zakrowski Donald A (SVP, Finance, & CAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-01 Common Stock M 4810 Acquired 9518 Direct
2023-12-01 Common Stock F 2142 $591.04 Disposed 7376 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-01 Restricted Stock Unit $ M 4810 Disposed 2023-12-01 Common Stock (4810) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1709 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.